The size of the High-Performance Liquid Chromatography Market in Europe was around USD 1.19 Billion in 2020. It is expected to grow at a CAGR of 5.2% to reach 1.52 Billion by 2025.
High-performance liquid chromatography is a procedure in investigative science used to recognize and measure every part of a blend. It depends on pumps to pass a pressurized fluid dissolvable containing the sample blend through a section loaded with a strong adsorbent material. Every part in the sample collaborates somewhat contrastingly with the adsorbent material, causing diverse stream rates for the distinctive segments and prompting the partition of the segments as they stream out.
HPLC has been utilized for manufacturing (production process of pharmaceutical and biological products), legal (spotting performance enhancement drugs in urine), research (splitting the constituents of a complex biological sample), and medical (sensing vitamin D levels in blood serum) purposes. HPLC is differentiated from traditional ("low pressure") liquid chromatography as operational pressures are considerably higher (50–350 bar), while normal liquid chromatography technique usually relies on the force of gravity to pass the mobile phase through the column.
The rising need for High-performance liquid chromatography in life sciences, increasing R&D activities, and growing quality of High-performance liquid chromatography techniques are some of the key driving factors of the market. The growth of the market is restricted by the high cost of HPLC systems.
This research report has been segmented and sub-segmented into the following categories:
By Product:
By Instruments:
By Consumables:
By Application:
By Country:
Regionally, Europe occupies the second largest market share after North America. Growing R&D activities and presence of key players is likely to fuel the market expansion in Europe.
Notable companies leading the European high-performance liquid chromatography market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Systems
5.1.2.2 Detectors
5.1.2.3 Pumps
5.1.2.4 Fraction Collectors
5.1.3 Consumables
5.1.3.1 Columns
5.1.3.2 Filters
5.1.3.3 Vials
5.1.3.4 Tubes
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Clinical research
5.2.3 Diagnostics
5.2.4 Forensics
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Waters Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Agilent Technologies
8.3 Shimadzu Corporation
8.4 Thermo Fisher Scientific Inc
8.5 GE Healthcare
8.6 PerkinElmer Inc.
8.7 Bio-Rad Laboratories Inc
8.8 Gilson Inc.
8.9 Phenomenex Inc.
8.10 JASCO Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
